Advertisement

Pyramidal Excision for Early Rectal Cancer and Special Closure Techniques

  • Giovanni Lezoche
  • Mario Guerrieri
  • Emanuele Lezoche
Chapter

Abstract

No other topic has had similar dramatic changes such as the therapy of low rectal cancer in the last two decades. The changes are not related only to the endoluminal technologies but mainly by the acceptance by colorectal surgeons that more aggressive surgery does not improve oncologic results in all stages of the disease. So colorectal surgeons are going through the same revolution that occurred in the 1980s for breast cancer. The locoregional resection of rectum and mesorectum, that we call “pyramidal excision” (PE), is the counterpart of the “lumpectomy” for breast cancer. After neoadjuvant therapy in T2-3 No tumors, the long-term results obtained by PE has shown the same oncological results of TME, but with the advantages, especially in the elderly patients, of no postoperative mortality or life-threatening complication. Postoperative morbidity is modest, and at six months no functional sequelae are reported.

Keywords

Pyramidal excision Early rectal cancer Low rectal cancer Rectal tumors TAMIS TEM 

References

  1. 1.
    Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, Warren B, Mortensen NJ. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg. 2009;96:280–90.  https://doi.org/10.1002/bjs.6456.CrossRefPubMedGoogle Scholar
  2. 2.
    Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum. 1995;38(12):1286–95.CrossRefGoogle Scholar
  3. 3.
    Riccardo N, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002;45(2):200–6.CrossRefGoogle Scholar
  4. 4.
    Doornebosch PG, Ferenschild FT, de Wilt JH, Dawson I, Tetteroo GW, de Graaf EJ. Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer. Dis Colon Rectum. 2010;53(9):1234–9.CrossRefGoogle Scholar
  5. 5.
    Stipa F, Giaccaglia V, Burza A. Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer. Dis Colon Rectum. 2012;55(3):262–9.CrossRefGoogle Scholar
  6. 6.
    Ayhan KM, Topçu Ö, Uçar K, Ulukent S, Ünal E, Erverdi N, Elhan A, Demirci S. Effect of sphincter-sacrificing surgery for rectal carcinoma on quality of life in muslim patients. Dis Colon Rectum. 2002;45:1359–66.CrossRefGoogle Scholar
  7. 7.
    Lezoche E, Guerrieri M, Paganini AM, Baldarelli M, De Sanctis A, Lezoche G. Long-term results in patients with T2–3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg. 2005;92(12):1546–52.CrossRefGoogle Scholar
  8. 8.
    Quaresima S, Paganini AM, D’Ambrosio G, Ursi P, Balla A, Lezoche E. A modified sentinel lymph node technique combined with endoluminal loco-regional resection for the treatment of rectal tumours: a 14-year experience. Color Dis. 2017;19(12):1100–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Giovanni Lezoche
    • 1
  • Mario Guerrieri
    • 1
  • Emanuele Lezoche
    • 2
  1. 1.Università Politecnica delle MarcheAnconaItaly
  2. 2.Università di Roma “SAPIENZA”RomeItaly

Personalised recommendations